SRPT
Sarepta Therapeutics Inc
18.70$
+1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 759.6 | 331.2 | 103.0 | 56.1 | – | – | – | – | 40.9 | – | |
| 2,364.6 | 276.1 | 76.2 | 32.6 | 27.2 | 23.1 | 23.6 | 35.9 | 39.0 | 24.9 | 26.4 | 32.6 | 15.3 | 25.0 | 18.3 | 27.8 | 22.3 | 24.8 | 10.3 | 10.3 | 11.4 | 10.3 | 8.9 | 7.9 | 11.1 | 12.2 | 12.5 | 10.1 | 9.7 | 8.2 | 9.1 | 10.4 | 7.6 | 6.9 | 2.8 | 0.7 | 0.8 | 1.0 | 1.2 | 1.0 | |
| 7.3 | 4.4 | 3.9 | 4.9 | 4.0 | 4.5 | 6.2 | 12.4 | 16.7 | 7.3 | 6.3 | 10.2 | 5.6 | 11.7 | 6.5 | 12.0 | 12.4 | 17.6 | 11.1 | 12.8 | 15.7 | 7.8 | 8.0 | 9.0 | 22.5 | 29.6 | 17.0 | 13.7 | 14.1 | 11.8 | 13.4 | 14.5 | 10.3 | 8.6 | 5.4 | 1.3 | 1.5 | 2.0 | 1.8 | 1.2 | |
| 2,047.5 | 256.5 | 64.2 | 29.9 | 21.5 | 22.0 | 23.0 | 36.0 | 40.1 | 25.5 | 25.8 | 31.8 | 14.8 | 24.6 | 16.1 | 26.0 | 21.1 | 23.9 | 10.0 | 9.7 | 11.0 | 9.2 | 8.7 | 8.1 | 11.6 | 12.8 | 12.8 | 10.8 | 10.7 | 8.9 | 9.7 | 11.0 | 8.3 | 7.0 | 3.2 | 1.0 | 1.0 | 1.0 | 1.4 | 1.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 142.5 | 135.9 | 72.5 | 41.8 | – | 68.0 | – | – | 24.3 | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 28.4 | 53.8 | 237.9 | 531.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 25.0 | – | |
| -6.8% | -16.9% | -15.3% | -16.1% | -10.8% | -7.1% | -5.0% | -3.2% | -3.2% | -6.0% | -6.6% | -4.8% | -8.6% | -5.4% | 3.5% | 1.9% | 0.4% | 0.2% | -13.4% | -12.6% | -8.8% | -6.7% | -5.7% | -5.3% | -3.0% | -3.1% | -3.9% | -5.3% | -5.7% | -5.8% | -5.1% | -3.4% | -3.8% | -2.7% | -11.2% | -24.9% | -20.1% | -14.1% | 4.0% | -6.9% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -12,423.4% | -2,037.4% | -257.5% | 39.2% | 96.1% | 95.2% | 93.7% | 92.2% | 91.0% | 88.6% | 87.4% | 85.5% | 85.2% | 85.1% | 86.0% | 87.9% | 88.6% | 88.3% | 87.2% | 86.8% | 86.4% | 86.2% | 86.1% | 85.1% | 83.9% | 85.0% | 85.3% | 86.1% | 87.6% | 87.9% | 88.2% | 88.3% | 85.9% | 83.2% | 81.8% | 79.3% | 76.3% | 61.8% | 62.4% | 58.6% | |
| -19,376.5% | -4,920.3% | -1,131.6% | -436.0% | -230.6% | -111.0% | -80.4% | -84.2% | -83.0% | -114.1% | -120.4% | -162.9% | -168.4% | -185.3% | -183.4% | -135.5% | -126.0% | -104.5% | -104.3% | -104.5% | -81.3% | -65.5% | -51.5% | -52.5% | -61.1% | -57.5% | -60.2% | -50.8% | -36.1% | -21.5% | -6.8% | 2.5% | 4.9% | 11.5% | -5.2% | 0.0% | -5.2% | -31.8% | -1.9% | -7.3% | |
| -19,432.9% | -4,930.2% | -567.0% | -218.7% | -112.1% | -32.8% | -83.9% | -89.6% | -89.5% | -120.2% | -124.7% | -165.5% | -169.9% | -187.8% | -161.0% | -117.8% | -121.3% | -102.6% | -122.8% | -105.7% | -75.3% | -59.7% | -46.6% | -60.7% | -81.8% | -75.4% | -114.3% | -90.5% | -62.5% | -43.1% | 1.2% | 3.1% | 7.4% | 12.4% | -11.1% | -2.3% | -11.2% | -32.5% | 3.0% | -6.9% | |
| -16,034.6% | -4,661.2% | -1,167.2% | -525.5% | -294.2% | -163.8% | -117.4% | -114.6% | -126.1% | -150.5% | -175.6% | -155.9% | -131.5% | -136.3% | 64.5% | 51.6% | 9.4% | 4.7% | -138.6% | -130.5% | -101.2% | -68.6% | -50.5% | -41.6% | -32.9% | -38.3% | -48.1% | -53.2% | -55.7% | -47.3% | -46.6% | -35.1% | -29.3% | -18.5% | -31.2% | -18.3% | -16.1% | -14.4% | 4.9% | -6.7% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -59.6% | -79.4% | -28.8% | -32.9% | -16.5% | -6.4% | -21.9% | -31.0% | -38.3% | -35.1% | -29.9% | -51.9% | -62.3% | -87.4% | -57.3% | -50.9% | -67.3% | -72.7% | -131.5% | -130.8% | -103.5% | -45.1% | -41.6% | -69.7% | -166.2% | -182.7% | -156.5% | -122.4% | -90.4% | -62.4% | 1.8% | 4.4% | 10.0% | 15.4% | -21.7% | -4.3% | -20.6% | -62.5% | 4.3% | -8.9% | |
| -50.0% | -63.0% | -24.1% | -27.6% | -14.4% | -3.9% | -13.1% | -17.3% | -20.7% | -22.0% | -20.5% | -32.6% | -36.4% | -39.2% | -22.3% | -18.4% | -21.6% | -18.6% | -25.5% | -23.0% | -18.3% | -13.3% | -11.7% | -16.9% | -22.7% | -22.5% | -36.4% | -29.0% | -22.2% | -16.4% | 0.5% | 1.4% | 3.4% | 5.9% | -7.2% | -1.6% | -7.8% | -21.3% | 2.0% | -4.3% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -397 | -106 | -261 | -157 | -586 | -169 | -126 | 29 | 294 | 184 | -206 | -270 | -167 | -145 | -900 | -787 | -575 | -489 | -210 | -364 | -283 | -747 | -135 | 232 | 504 | 593 | 363 | 710 | 1,017 | 827 | 812 | 843 | 1,030 | 48 | 897 | 629 | 432 | 39 | 374 | 276 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.5 | 6.9 | 5.5 | 0.2 | – | 17.4 | – | – | 3.0 | – | |
| 83.9% | 79.4% | 83.9% | 83.9% | 87.1% | 60.3% | 59.7% | 56.1% | 54.1% | 62.9% | 68.7% | 62.9% | 58.5% | 44.9% | 38.8% | 36.2% | 32.1% | 25.5% | 19.4% | 17.6% | 17.6% | 29.5% | 28.0% | 24.2% | 13.7% | 12.3% | 23.3% | 23.7% | 24.6% | 26.3% | 29.8% | 31.5% | 33.9% | 38.5% | 33.0% | 36.9% | 37.8% | 34.1% | 47.3% | 47.9% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.6 | 0.6 | 0.8 | 0.5 | 0.4 | 0.5 | 0.6 | 0.8 | 0.8 | 0.8 | 1.0 | 1.3 | 2.4 | 2.7 | 2.8 | 1.5 | 1.3 | 1.5 | 3.6 | 4.1 | 1.7 | 2.1 | 2.0 | 1.5 | 1.3 | 1.1 | 1.0 | 0.8 | 1.0 | 0.8 | 0.8 | 0.7 | 0.6 | 0.6 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -5.05 | -4.89 | -2.20 | -2.26 | -1.87 | -0.79 | -2.63 | -3.30 | -3.70 | -5.27 | -5.62 | -7.71 | -8.36 | -9.68 | -8.58 | -6.80 | -7.65 | -7.04 | -8.86 | -7.96 | -6.09 | -5.24 | -4.09 | -5.79 | -8.17 | -8.01 | -12.65 | -10.23 | -7.77 | -5.08 | 0.17 | 0.48 | 1.21 | 2.17 | -2.55 | -0.54 | -2.71 | -6.81 | 0.53 | -1.30 | |
| 0.03 | 0.10 | 0.39 | 1.03 | 1.67 | 2.40 | 3.14 | 3.69 | 4.14 | 4.38 | 4.51 | 4.66 | 4.92 | 5.15 | 5.33 | 5.77 | 6.31 | 6.86 | 7.22 | 7.52 | 8.08 | 8.79 | 8.78 | 9.54 | 10.00 | 10.62 | 11.06 | 11.31 | 12.43 | 11.77 | 14.16 | 15.18 | 16.33 | 17.53 | 22.94 | 23.27 | 24.08 | 20.98 | 17.92 | 18.73 | |
| 8.47 | 6.16 | 7.66 | 6.87 | 11.33 | 12.28 | 12.02 | 10.68 | 9.66 | 15.04 | 18.80 | 14.86 | 13.42 | 11.07 | 14.98 | 13.38 | 11.36 | 9.68 | 6.74 | 6.08 | 5.88 | 11.62 | 9.82 | 8.30 | 4.92 | 4.38 | 8.08 | 8.35 | 8.60 | 8.14 | 9.70 | 10.86 | 12.16 | 14.08 | 11.74 | 12.73 | 13.17 | 10.88 | 12.35 | 14.49 | |
| -4.16 | -4.63 | -4.54 | -5.43 | -4.91 | -3.94 | -3.68 | -4.22 | -5.22 | -6.60 | -7.92 | -7.26 | -6.47 | -7.03 | 3.44 | 2.98 | 0.59 | 0.32 | -10.00 | -9.82 | -8.18 | -6.03 | -4.43 | -3.97 | -3.29 | -4.07 | -5.33 | -6.02 | -6.92 | -5.57 | -6.60 | -5.32 | -4.78 | -3.25 | -7.16 | -4.26 | -3.88 | -3.03 | 0.87 | -1.25 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.